Journal: The Journal of investigative dermatology
Article Title: Type I IL-1 receptor mediates IL-1 and intracellular IL-1 receptor antagonist effects in skin inflammation.
doi: 10.1038/sj.jid.5700803
Figure Lengend Snippet: Figure 2. PMA-induced skin inflammation in absence of IL-1 activity. Results of histological scoring for (a) epidermal thickness and (b) dermal inflammatory cell infiltration are shown for PMA-treated WT (n¼ 8), IL-1RI/ (n¼ 5), icIL-1Ra1 tg (n¼ 4), IL-1Ra/ icIL-1Ra1 tg (n¼ 5), IL-1Ra/ IL-1RI/ (n¼ 5) and IL-1Ra/ IL-1RI/ icIL-1Ra1 tg mice (n¼ 8). Results shown represent the mean7SEM for each group of mice. *Po0.05 versus WT mice, as assessed by analysis of variance (ANOVA). Epidermal thickness was similar in all groups of mice, whereas inflammatory cell infiltration was significantly decreased in mice lacking IL-1RI and/or overexpressing icIL-1Ra1, in presence or in absence of endogenous IL-1Ra. (c) IL-1a mRNA expression was analyzed by RNase protection assay and quantified by phosphorimaging in PMA-treated WT (n¼ 8), IL-1RI/ (n¼ 5), icIL-1Ra1 tg (n¼ 4), IL-1Ra/ icIL-1Ra1 tg (n¼ 5), IL-1Ra/ IL-1RI/ (n¼ 5), and IL-1Ra/ IL-1RI/ icIL-1Ra1 tg mice (n¼ 8). Results are expressed as the ratio of IL-1a over L32 mRNA expression. Results shown represent the mean7SEM for each group of mice. *Po0.05 versus WT mice, as assessed by ANOVA. AU, arbitrary units. IL-1a mRNA levels were significantly elevated in icIL-1Ra1 tg and in IL-1Ra/ icIL-1Ra1 tg, as compared with WT mice. (d) Circulating SAA levels were assessed by ELISA in the serum of PMA-treated WT (n¼ 8), IL-1RI/ (n¼ 5), icIL-1Ra1 tg (n¼ 4), IL-1Ra/ icIL-1Ra1 tg (n¼ 5), IL-1Ra/ IL-1RI/ (n¼ 5) and IL-1Ra/ IL-1RI/ icIL-1Ra1 tg mice (n ¼ 8). Results shown represent the mean7SEM for each group of mice. *Po0.05 versus WT mice, as assessed by ANOVA. SAA levels were significantly lower in PMA-treated mice lacking IL-1RI and/or overexpressing icIL-1Ra1, in presence or in absence of endogenous IL-1Ra.
Article Snippet: Sections were then stained using a rabbit polyclonal anti-IL-1a antibody (sc-7929; Santa Cruz Biotechnologies, Santa Cruz, CA; 1/100) in phosphate-buffered saline containing 1.5% BSA and 5% normal goat serum overnight at 41C.
Techniques: Activity Assay, Expressing, Rnase Protection Assay, Enzyme-linked Immunosorbent Assay